# Alcoholism and Schizophrenia: Effects of Clozapine

> **NCT00169026** · PHASE4 · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 64 (—)

## Conditions studied

- Schizophrenia
- Dual Diagnosis
- Schizoaffective Disorder
- Psychotic Disorder
- Substance Abuse
- Alcohol Abuse

## Interventions

- **DRUG:** Clozapine versus typical (conventional) and atypical antipsychotic medications

## Key facts

- **NCT ID:** NCT00169026
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-05
- **Primary completion:** —
- **Final completion:** 2004-01
- **Target enrollment:** 64 (—)
- **Last updated:** 2018-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169026, "Alcoholism and Schizophrenia: Effects of Clozapine". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00169026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*